Elevated plasma levels of the long pentraxin, pentraxin 3, in severe dengue virus infections

Journal of Medical Virology

Volumn 76, Issue 4, 2005, Pages 547-552

  Mairuhu, Albert T A ^a   Peri, Giuseppe ^b   Setiati, Tatty E ^c   Hack, C Erik ^d,e,f   Koraka, Penelopie ^g   Soemantri, Augustinus ^c   Osterhaus, Albert D M E ^g   Brandjes, Dees P M ^a   Van Der Meer, Jos W M ^h   Mantovani, Alberto ^b   Van Gorp, Eric C M ^a  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b UNIVERSITY OF MILAN   (Italy)

^c Dr Kariadi Hospital   (Indonesia)

^d SANQUIN RESEARCH   (Netherlands)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^g ERASMUS MEDICAL CENTER   (Netherlands)

^h RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acute phase reaction; C reactive protein; Dengue hemorrhagic fever; Dengue shock syndrome

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; PENTRAXIN; PENTRAXIN 3; UNCLASSIFIED DRUG;

ACUTE PHASE RESPONSE; ADOLESCENT; ARTICLE; CRITICAL ILLNESS; DENGUE; DENGUE VIRUS; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PROGNOSIS; SCHOOL CHILD;

C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; DENGUE; DENGUE HEMORRHAGIC FEVER; FEMALE; HUMANS; INDONESIA; MALE; SERUM AMYLOID P-COMPONENT;

DENGUE VIRUS;

EID: 21744447375     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20397     Document Type: Article

References (16)

1. Bethell DB, Flobbe K, Cao XT, Day NP, Pham TP, Buurman WA, Cardosa MJ, White NJ, Kwiatkowski D. 1998. Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. J Infect Dis 177:778-782.
2. Gabay C, Kushner I. 1999. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448-454.
3. Garlanda C, Hirsch E, Bozza S, Salustri A, De Acetis M, Nota R, Maccagno A, Riva F, Bottazzi B, Peri G, Doni A, Vago L, Botto M, De Santis R, Carminati P, Siracusa G, Altruda F, Vecchi A, Romani L, Mantovani A. 2002. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature 420:182-186.
4. Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, Nisalak A, Lew R, Innis BL, Kurane I, Rothman AL, Ennis FA. 1999. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis 179:755-762.
5. Groen J, Koraka P, Velzing J, Copra C, Osterhaus AD. 2000. Evaluation of six immunoassays for detection of dengue virus-specific immunoglobulin M and G antibodies. Clin Diagn Lab Immunol 7:867-871.
6. Juffrie M, Meer GM, Hack CE, Haasnoot K, Sutaryo, Veerman AJ, Thijs LG. 2001. Inflammatory mediators in dengue virus infection in children: Interleukin-6 and its relation to C-reactive protein and secretory phospholipase A2. Am J Trop Med Hyg 65:70-75.
7. Latini R, Maggioni AP, Peri G, Gonzini L, Lucci D, Mocarelli P, Vago L, Pasqualini F, Signorini S, Soldateschi D, Tarli L, Schweiger C, Fresco C, Cecere R, Tognoni G, Mantovani A, Lipid Assessment Trial Italian Network (LATIN) Investigators. 2004. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation 110:2349-2354.
8. Mantovani A, Garlanda C, Bottazzi B. 2003. Pentraxin 3, a non-redundant soluble pattern recognition receptor involved in innate immunity. Vaccine 21:S43-S47.
9. Mohan B, Patwari AK, Anand VK. 2000. Hepatic dysfunction in childhood dengue infection. J Trop Pediatr 46:40-43.
10. Muller B, Peri G, Doni A, Torri V, Landmann R, Bottazzi B, Mantovani A. 2001. Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients. Crit Care Med 29:1404-1407.
11. Nguyen TH, Lei HY, Nguyen TL, Lin YS, Huang KJ, Le BL, Lin CF, Yeh TM, Do QH, Vu TQ, Chen LC, Huang JH, Lam TM, Liu CC, Halstead SB. 2004. Dengue hemorrhagic fever in infants: A study of clinical and cytokine profiles. J Infect Dis 189:221-232.
12. Pancharoen C, Rungsarannont A, Thisyakorn U. 2002. Hepatic dysfunction in dengue patients with various severity. J Med Assoc Thai 85:3298-3301.
13. Peri G, Introna M, Corradi D, Iacuitti G, Signorini S, Avanzini F, Pizzetti F, Maggioni AP, Moccetti T, Metra M, Cas LD, Ghezzi P, Sipe JD, Re G, Olivetti G, Mantovani A, Latini R. 2000. PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. Circulation 102:636-641.
14. van Gorp EC, Minnema MC, Suharti C, Mairuhu AT, Brandjes DP, ten Gate H, Hack CE, Meijers JC. 2001. Activation of coagulation factor XI, without detectable contact activation in dengue haemorrhagic fever. Br J Haematol 113:94-99.
15. Wolbink GJ, Bossink AW, Groeneveld AB, de Groot MC, Thijs LG, Hack CE. 1998. Complement activation in patients with sepsis is in part mediated by C-reactive protein. J Infect Dis 177:81-87.
16. World Health Organisation. 1997. Dengue hemorrhagic fever: Diagnosis, treatment, prevention and control, 2nd edn. Geneva, Switzerland: World Health Organization.